Note 6. Earnings Per Share of Common Stock
The table below shows a reconciliation of the numerator and denominator for basic and diluted earnings per share calculations for the periods indicated.
|
|
Three Months Ended March 31, |
|
|
|
2017 |
|
|
2016 |
|
Numerator: |
|
|
|
|
|
|
|
|
Net income attributable to Chemours |
|
$ |
150 |
|
|
$ |
51 |
|
Denominator: |
|
|
|
|
|
|
|
|
Weighted average number of common shares
outstanding- Basic |
|
|
183,408,309 |
|
|
|
181,281,166 |
|
Dilutive effect of the Company’s employee
compensation plans 1 |
|
|
5,741,621 |
|
|
|
221,974 |
|
Weighted average number of common shares outstanding -
Diluted 1 |
|
|
189,149,930 |
|
|
|
181,503,140 |
|
1 |
Diluted earnings per share is calculated using net income available to common shareholders divided by diluted weighted-average shares of common shares outstanding during each period, which includes unvested restricted shares. Diluted earnings per share considers the impact of potentially dilutive securities except in periods in which there is a loss because the inclusion of the potential common shares would have an antidilutive effect. |
The following average number of stock options were antidilutive and, therefore, were not included in the diluted earnings per share calculation:
|
|
Three Months Ended March 31, |
|
|
|
2017 |
|
|
2016 |
|
Average number of stock options |
|
|
169,118 |
|
|
|
8,701,474 |
|
|